Serum fetuin-A concentrations are inversely related to cytokine concentrations in patients with chronic renal failure

Cytokine

Volumn 44, Issue 3, 2008, Pages 323-327

  Dervisoglu, Erkan ^a   Kir, Hale Maral ^a   Kalender, Betul ^a   Caglayan, Cigdem ^a   Eraldemir, Ceyla ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Chronic kidney disease; Fetuin A; Inflammation; Proinflammatory cytokines; Vascular calcification

Indexed keywords

FETUIN A; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

ALPHA-FETOPROTEINS; CYTOKINES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED;

EID: 57449100061     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.08.014     Document Type: Article

References (22)

1. Foley R.N., Parfrey P.S., and Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 (1998) 112-119
2. Cozzolino M., Galassi A., Biondi M.L., Turri O., Papagni S., Mongelli N., et al. Serum fetuin-A levels link inflammation and cardiovascular calcification in haemodialysis patients. Am J Nephrol 26 (2006) 423-429
3. Pecovnik-Balon B. Cardiovascular calcification in patients with end-stage renal disease. Ther Apher Dial 9 (2005) 208-210
4. Herbelin A., Urena P., Nguyen A.T., Zingraff J., and Descamps-Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 39 (1991) 954-960
5. Pereira B.J., Shapiro L., King A.J., Falagas M.E., Strom J.A., and Dinarello C.A. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and haemodialysis patients. Kidney Int 45 (1994) 890-896
6. van Riemsdijk-van Overbeeke I.C., Baan C.C., Hesse C.J., Loonen E.H., Niesters H.G., Zietse R., et al. TNF-α: mRNA, plasma protein levels and soluble receptors in patients on chronic haemodialysis, on CAPD and with end-stage renal failure. Clin Nephrol 53 (2000) 115-123
7. Tintut Y., Patel J., Parhami F., and Demer L.L. Tumor necrosis factor-α promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102 (2000) 2636-2642
8. Reilly M.P., Rohatgi A., McMahon K., Wolfe M.L., Pinto S.C., Rhodes T., et al. Plasma cytokines, metabolic syndrome, and atherosclerosis in humans. J Investig Med 55 (2007) 26-35
9. Westenfeld R., Jahnen-Dechent W., and Ketteler M. Vascular calcification and fetuin-A deficiency in chronic kidney disease. Trends Cardiovasc Med 17 (2007) 124-128
10. Schafer C., Heiss A., Schwarz A., Westenfeld R., Ketteler M., Floege J., et al. The serum protein α 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112 (2003) 357-366
11. Lebreton J.P., Joisel F., Raoult J.P., Lannuzel B., Rogez J.P., and Humbert G. Serum concentration of human α 2 HS glycoprotein during the inflammatory process: evidence that α 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 64 (1979) 1118-1129
12. Heiss A., DuChesne A., Denecke B., Grötzinger J., Yamamoto K., Renne T., et al. Structural basis of calcification inhibition by α 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 278 (2003) 13333-13341
13. Ketteler M., Bongartz P., Westenfeld R., Wildberger J.E., Mahnken A.H., Böhm R., et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361 (2003) 827-833
14. Floege J., and Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant 19 (2004) 59-66
15. Cozzolino M., Galassi A., Biondi M.L., Butti A., Russo M., Longhini C., et al. Decreased serum fetuin-A levels after a single haemodialysis session. Nephrol Dial Transplant 22 (2007) 290-291
16. Ketteler M., Westenfeld R., Schlieper G., Brandenburg V., and Floege J. Missing inhibitors of calcification: general aspects and implications in renal failure. Pediatr Nephrol 20 (2005) 383-388
17. Moe S.M., and Chen N.X. Inflammation and vascular calcification. Blood Purif 23 (2005) 64-71
18. Raggi P., Giachelli C., and Bellasi A. Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis. Nat Clin Pract Cardiovasc Med 4 (2007) 26-33
19. Wang A.Y., Woo J., Wang M., Sea M.M., Ip R., Li P.K., et al. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12 (2001) 1927-1936
20. Stenvinkel P., Ketteler M., Johnson R.J., Lindholm B., Pecoits-Filho R., Riella M., et al. IL-10, IL-6, and TNF-α: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int 67 (2005) 1216-1233
21. Bommer J., and Jaber B.L. Ultrapure dialysate: facts and myths. Semin Dial 19 (2006) 115-119
22. Teruel J.L., Marcen R., Ocana J., Fernandez-Lucas M., Rivera M., Tabernero G., et al. Clinical significance of C-reactive protein in patients on haemodialysis: a longitudinal study. Nephron Clin Pract 100 (2005) 140-145